Literature DB >> 29870448

Minimum Five-Year Outcomes of Hip Arthroscopy for the Treatment of Femoroacetabular Impingement and Labral Tears in Patients with Obesity: A Match-Controlled Study.

Itay Perets1,2, Danil Rybalko1, Edwin O Chaharbakhshi1,3, Brian H Mu1, Austin W Chen1, Benjamin G Domb1,4.   

Abstract

BACKGROUND: Obesity is a negative prognostic factor for various surgical procedures. The purpose of this study was to compare patients with obesity who underwent hip arthroscopy for femoroacetabular impingement and labral tears with a match-controlled group of normal-weight patients.
METHODS: Data were prospectively collected and retrospectively reviewed for patients who underwent arthroscopy between February 2008 and December 2011. Inclusion criteria were treatment for femoroacetabular impingement and labral tears and completed preoperative patient-reported outcomes and visual analog scale (VAS) for pain. Exclusion criteria were previous ipsilateral hip conditions or preoperative Tönnis grade of ≥2. Patients with obesity (body mass index [BMI] of ≥30 kg/m) were matched and were compared with normal-weight patients (BMI of 18.5 to 24.99 kg/m) using a 1:1 ratio by age at the time of the surgical procedure within 5 years, sex, acetabular Outerbridge grade (0 or 1 compared with 2, 3, or 4), and capsular treatment.
RESULTS: Of the 96 obesity cases with follow-up, 74 were pair-matched to control cases. The mean BMI was 34.3 kg/m for the obesity group and 22.7 kg/m for the control group (p < 0.0001). The mean follow-up time was 71.6 months for the obesity group and 71.3 months for the control group (p = 0.41). All mean preoperative patient-reported outcomes and VAS scores for patients without conversion to total hip arthroplasty were significantly worse in the obesity group: modified Harris hip score (p = 0.0001), Non-Arthritic Hip Score (p = 0.0001), Hip Outcome Score Sports-Specific Scale (HOS-SSS) (p = 0.015), and VAS (p = 0.01). No significant differences were observed with regard to demographic characteristics, intraoperative findings, procedures, follow-up scores, magnitudes of improvement, or secondary arthroscopy rates (p > 0.05). Both groups demonstrated significant improvements in mean outcome scores at ≥5 years (p < 0.0001). In both groups, no significant differences were detected in mean outcome scores between 2 years and ≥5 years (p > 0.05). The conversion rate to total hip arthroplasty was 29.7% for the obesity group and 14.9% for the control group (relative risk, 2.0 [95% confidence interval, 1.1 to 3.8]; p = 0.04).
CONCLUSIONS: Hip arthroscopy for the treatment of femoroacetabular impingement and labral tears in patients with obesity yielded significant improvements at ≥5 years; these results were similar to a matched group of normal-weight patients. However, patients with obesity demonstrated a twofold increased risk of conversion to total hip arthroplasty. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2018        PMID: 29870448     DOI: 10.2106/JBJS.17.00892

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  9 in total

1.  CORR Insights®: Can Dynamic Ultrasonography of the Hip Reliably Assess Anterior Femoral Head Translation?

Authors:  David R Maldonado
Journal:  Clin Orthop Relat Res       Date:  2019-05       Impact factor: 4.176

2.  Pain Catastrophizing and Kinesiophobia Affect Return to Sport in Patients Undergoing Hip Arthroscopy for the Treatment of Femoroacetabular Impingement.

Authors:  Robert B Browning; Ian M Clapp; Thomas D Alter; Benedict U Nwachukwu; Shane J Nho
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-05-27

3.  What Is the Survivorship After Hip Arthroscopy for Femoroacetabular Impingement? A Large-database Study.

Authors:  Jie J Yao; Sara B Cook; Albert O Gee; Christopher Y Kweon; Mia S Hagen
Journal:  Clin Orthop Relat Res       Date:  2020-10       Impact factor: 4.755

4.  Outcomes of Hip Arthroscopy for Femoroacetabular Impingement in Chinese Patients Aged 50 Years or Older.

Authors:  Feng Gao; Baiqing Zhang; Bo Hu; Ming Lu; Mingyang An; Yufeng Liu; Yehan Fang; Gang Zhao; Chao Shi; Jingbin Zhou; Yujie Liu; Chunbao Li
Journal:  Orthop Surg       Date:  2020-05-27       Impact factor: 2.071

5.  Defining the Clinically Meaningful Outcomes for Arthroscopic Treatment of Femoroacetabular Impingement Syndrome at Minimum 10-Year Follow-up: The Timing of Surgery Is Crucial.

Authors:  Alexander Zimmerer; Viktor Janz; Christian Sobau; Georgi I Wassilew; Wolfgang Miehlke
Journal:  Orthop J Sports Med       Date:  2021-02-25

Review 6.  Evaluation of outcome reporting trends for femoroacetabular impingement syndrome- a systematic review.

Authors:  Ida Lindman; Sarantos Nikou; Axel Öhlin; Eric Hamrin Senorski; Olufemi Ayeni; Jon Karlsson; Mikael Sansone
Journal:  J Exp Orthop       Date:  2021-04-23

7.  Hyperlipidemia does not influence clinical outcome in arthroscopic treatment of femoroacetabular impingement syndrome.

Authors:  Fan Yang; Hong-Jie Huang; Xin Zhang; Jian-Quan Wang; Zhu Zhang
Journal:  J Orthop Surg Res       Date:  2022-08-31       Impact factor: 2.677

8.  What is the Role of Kinesiophobia and Pain Catastrophizing in Outcomes After Hip Arthroscopy for Femoroacetabular Impingement Syndrome?

Authors:  Ian M Clapp; Benedict U Nwachukwu; Edward C Beck; Jonathan P Rasio; Thomas Alter; Bradley Allison; Shane J Nho
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-01-08

9.  Revision Surgery and Progression to Total Hip Arthroplasty After Surgical Correction of Femoroacetabular Impingement: A Systematic Review.

Authors:  Filippo Migliorini; Nicola Maffulli; Alice Baroncini; Jörg Eschweiler; Markus Tingart; Marcel Betsch
Journal:  Am J Sports Med       Date:  2021-06-03       Impact factor: 6.202

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.